ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

About Bios Partners

Bios Partners is a venture capital firm founded in 2014. It is primarily based out of Fort Worth, United States. As of Sep 2024, Bios Partners has invested in 17 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $15M Series C round of ONL Therapeutics along with Exsight Ventures. This round also saw participation from Visionary Ventures and other investors.
Overall, Bios Partners portfolio has seen 7 IPOs and 2 acquisitions including key companies like Lantern Pharma, Taysha Gene Therapies and Cognition Therapeutics. A lot of funds co-invest with Bios Partners, with names like DEFTA Partners sharing a substantial percentage of its portfolio.
Bios Partners has team of 12 people including 5 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Get Bios Partners' portfolio delivered to your inbox!

Bios Partners' Investment Trends by Stage

Bios Partners has made 7 investments in Series A stage, 3 investments in Series B stage and 1 investment in Seed stage.

Bios Partners' Investment Trends by Sector

Bios Partners has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Artificial Intelligence - Industry Applications, HealthTech and Robotics - Industry Applications. Notably, it has invested in 16 Tech companies, 13 Enterprise (B2B) companies, 2 Tech hardware companies and 1 company focusing on Artificial intelligence.
Here are Bios Partners' investment trends by sector:
Note: We have considered here, only first round of investments
Breakdown of Bios Partners' investments by sectorsLife Sciences (11)High Tech (3)
Sector
No. of Investments
Life Sciences
11
High Tech
3
Artificial Intelligence - Industry Applications
1
HealthTech
1
Robotics - Industry Applications
1
Others
1

Bios Partners' Investment Trends by Geography

Bios Partners has made most investments in United States (17).

Bios Partners' recent investments

Bios Partners has not made any investment in 2025 so far.
Here are the most recent investments by Bios Partners:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Sep 13, 2024
United States
Series D
$65M
Mar 08, 2023
United States
Series C
$15M
Sep 23, 2021
United States
Seed
$19M
[+1]
Jul 23, 2021
United States
Series A
$27.1M
Dec 22, 2020
United States
Series B
$46.9M
lockGet the detailed list of all investments by Bios Partners. Download now!

IPOs and Publicly Listed companies in Bios Partners' Portfolio

7 of Bios Partners' portfolio companies have become public.ÌýOpus Genetics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 2024Ìýand Actuate Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $153M.
Here are Bios Partners' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Oct 24, 2024
Sep 23, 2021
Seed
$19M
Aug 13, 2024
Aug 28, 2018
Series A
$4.02M
Jun 16, 2023
Mar 17, 2017
Series A
$2.9M
Oct 08, 2021
-
-
-
Jul 30, 2021
-
-
-

Acquired companies in Bios Partners' Portfolio

2 companies from Bios Partners' portfolio have been acquired.ÌýThe most recent acquisition were Lung Therapeutics in Oct 2023Ìýby Aileron Therapeutics.
Here are Bios Partners' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Oct 31, 2023
May 18, 2017
Series B
$14.3M
Dec 20, 2016
-
-
-

Team profile of Bios Partners

Bios Partners has a team of 12 membersÌýincluding 5 Partners and 1 PrincipalÌýlocated in United States. Bios Partners' team does not sit on the board of any company as of now.
Here is a list of top team members in Bios Partners:
Name
Designation
Location
Board Memberships
Contact details
Partner
Fort Worth
-
Partner
Dallas
-
Partner
Fort Worth
-
Partner
Fort Worth
-
Partner
Dallas
-
Principal
Fort Worth
-
Associate
Fort Worth
-
Analyst
San Antonio
-
-
Analyst
Fort Worth
-
Analyst
Dallas
-
Analyst
Dallas
-
lockGet the full list of Bios Partners' team & partners for free. Download now!

Co-investors of Bios Partners

Over the past 8 years, 71 investors have co-invested in Bios Partners's portfolio companies.

  • Invested before Bios Partners:ÌýHHS, Breakout Labs and 19 others have invested in rounds before Bios Partners. There are 4 companies where HHS has invested before Bios Partners and 2 companies where Breakout Labs has invested before Bios Partners.
  • Top Co-investors of Bios Partners:Ìý19 investors entered a company along with Bios Partners. These include investors like DEFTA Partners (2 companies).
  • Invested after Bios Partners:ÌýA total of 31 investors have invested in Bios Partners's portfolio after their investments. Top Investors include (2 companies), HHS (2 companies) and (1 company).
Get full list of Bios Partners' co-investors delivered to your inbox!

Recent News related to Bios Partners

•
ForexTV•Sep 13, 2024•ONL Therapeutics, Johnson & Johnson Innovation, Bios Partners, Novartis Venture Fund and 1 other
•
WRAL TechWire•Jun 29, 2023•Opus Genetics, Bios Partners,
•
Clinical Trials Arena•Mar 09, 2023•ONL Therapeutics, Bios Partners, Alpine Visionary Venture, Visionary Ventures and 5 others
•
FinSMEs•Jan 13, 2022•ONL Therapeutics, Bios Partners, Johnson & Johnson Innovation, Kaitai Capital Management and 4 others
•
BioPharma-Reporter•Sep 23, 2021•Opus Genetics, , Bios Partners
•
GlobeNewswire•Dec 22, 2020•ONL Therapeutics, Bios Partners, Johnson & Johnson Innovation – JJDC, Kaitai Capital Management and 7 others
•
Business Wire•Oct 15, 2020•Azitra, Bayer, Connecticut Innovations, Bios Partners
•
PE Hub•Nov 12, 2019•Actuate Therapeutics, Bios Partners, Kairos Ventures, DEFTA Partners
•
Business Wire•Oct 15, 2019•Azitra, KdT Ventures, Bios Partners, Connecticut Innovations and 1 other
•
BioSpace•Jul 16, 2019•Trefoil Therapeutics, Bios Partners, Hatteras Venture Partners, Aju IB Investment and 8 others
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long